Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS

Journal of Neuroimmunology

Volumn 243, Issue 1-2, 2012, Pages 81-88

  Pranzatelli, Michael R ^a   Tate, Elizabeth D ^a   McGee, Nathan R ^a   Travelstead, Anna L ^a   Ransohoff, Richard M ^b   Ness, Jayne M ^c   Colliver, Jerry A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Adrenocorticotrophic hormone; BCA 1; Chemokines; Neuroblastoma; Paraneoplastic disorder; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CORTICOTROPIN; CXCL13 CHEMOKINE; DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CELL MIGRATION; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; OPSOCLONUS MYOCLONUS SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT RESPONSE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANTIGENS, CD; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL MOVEMENT; CHEMOKINE CXCL12; CHEMOKINE CXCL13; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; LONGITUDINAL STUDIES; MALE; OPSOCLONUS-MYOCLONUS SYNDROME; RECEPTORS, CXCR5;

EID: 84856959540     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.12.014     Document Type: Article

References (33)

1. Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 2006, 6:205-217.
2. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002, 16:67-76.
3. Berberich S., Förster R., Pabst O. The peritoneal micromilieu commits B cells to home to body cavities and the small intestine. Blood 2007, 109:4627-4634.
4. Bielekova B., Martin R. Development of biomarkers in multiple sclerosis. Brain 2004, 127:1463-1478.
5. Bowen M.B., Butch A.W., Parvin C.A., Levine A., Nahm M.H. Germinal center T cells are distinct helper-inducer T cells. Hum. Immunol. 1991, 31:67-75.
6. Bürkle A., Niedermeier M., Schmitt-Gräff A., Wierda W.G., Keating M.J., Burger J.A. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007, 110:3316-3325.
7. Carlsen H.S., Baekkevold E.S., Morton H.C., Haraldsen G., Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 2004, 104:3021-3027.
8. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286:2098-2102.
9. Fischer L., Korfel A., Pfeiffer S., Kiewe P., Volk H.D., Cakiroglu H., Widmann T., Thiel E. CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin. Cancer Res. 2009, 15:5968-5973.
10. Han Y., He T., Huang D.R., Pardo C.A., Ransohoff R.M. TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J. Clin. Invest. 2001, 108:425-435.
11. Hargreaves D.C., Hyman P.L., Lu T.T., Ngo V.N., Bidgol A., Suzuki G., Zou Y.R., Littman D.R., Cyster J.G. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 2001, 194:45-56.
12. Kim C.H., Lim H.W., Kim J.R., Rott L., Hillsamer P., Butcher E.C. Unique gene expression program of human germinal center T helper cells. Blood 2004, 104:1952-1960.
13. Kivisäkk P., Liu Z., Trebst C., Tucky B., Wu L., Stine J., Mack M., Rudick R.A., Campbell J.J., Ransohoff R.M. Flow cytometry analysis of chemokine receptor expression on cerebrospinal fluid leukocytes. Methods 2003, 29:319-325.
14. Klein R.S., Rubin J.B. Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol. 2004, 25:306-314.
15. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
16. Kuenz B., Lutterotti A., Ehling R., Gneiss C., Haemnerle M., Rainer C., Deisenhammer F., Schocke M., Berger T., Reindl M. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 2008, 3:e2559.
17. Lazarini F., Tham T.N., Casanova P., Arenzana-Seisdedos F., Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003, 42:139-148.
18. Lemire R.J., Loeser J.D., Leech R.W., Alvord E.C. Normal and Abnormal Development of the Human Nervous System 1975, Harper & Row, Hagerstown, Maryland.
19. Li M., Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 2008, 84:116-131.
20. McCandless E.E., Budde M., Lees J.R., Dorsey D., Lyng E., Klein R.S. IL-1R signaling within the CNS regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J. Immunol. 2009, 183:613-620.
21. Melchers F., Rolink A.G., Schaniel C. The role of chemokines in regulating cell migration during humoral immune responses. Cell 1999, 99:351-354.
22. Meraouna A., Cizeron-Clairac G., Panse R.L., Bismuth J., Truffault F., Tallaksen C., Berrih-Aknin S. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006, 108:432-440.
23. Pranzatelli M.R., Travelstead A.L., Tate E.D., Allison T.J., Moticka E.J., Franz D.N., Nigro M.A., Parke J.T., Stumpf D.A., Verhulst S.J. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 2004, 62:1526-1532.
24. Pranzatelli M.R., Travelstead A.L., Tate E.D., Allison T.J., Verhulst S.J. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov. Disord. 2004, 19:770-777.
25. Pranzatelli M.R., Tate E.D., Travelstead A.L., Barbosa J., Bergamini R.A., Civitello L., Franz D.N., Greffe B.S., Hanson R.D., Hurwitz C.A., Kalinyak K.A., Kelfer H., Khakoo Y., Mantovani J.F., Nicholson S.H., Sanders J.M., Wegner S. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J. Pediatr. Hematol. Oncol. 2006, 28:585-593.
26. Pranzatelli M.R., Tate E.D., Swan J.A., Travelstead A.L., Colliver J.A., Verhulst S.J., Crosley C.J., Graf W.D., Joseph S.A., Kelfer H.M., Raju G.P. B cell depletion therapy for new-onset opsoclonus-myoclonus. Mov. Disord. 2010, 25:238-242.
27. Pranzatelli M.R., Tate E.D., Travelstead A.L., Colliver J.A. Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus. J. Clin. Immunol. 2010, 30:106-113.
28. Raffaghello L., Conte M., De Grandis E., Pistoia V. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. Eur. J. Paediatr. Neurol. 2009, 13:219-223.
29. Rupprecht T.A., Plate A., Adam M., Wick M., Kastenbauer S., Schmidt C., Klein M., Pfister H.W., Koedel U. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute lyme neuroborreliosis. J. Neuroinflammation 2009, 6:42.
30. Sellebjerg F., Börnsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J.L., Sørensen P.S. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 2009, 73:2003-2010.
31. Tate E.D., Allison T.J., Pranzatelli M.R., Verhulst S.J. Neuroepidemiologic trends in 105 U.S. cases of pediatric opsoclonus-myoclonus. J. Pediatr. Oncol. Nurs. 2005, 22:8-19.
32. ten Donkelaar H.J., Lammens M. Development of the human cerebellum and its disorders. Clin. Perinatol. 2009, 36:513-530.
33. Vissers J.L., Hartgers F.C., Lindhout E., Figdor C.G., Adema G.J. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur. J. Immunol. 2001, 31:1544-1549.